Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08DWH
|
|||
Former ID |
DIB007449
|
|||
Drug Name |
Idrapril
|
|||
Synonyms |
LG-32001
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Hypertension [ICD-11: BA00-BA04; ICD-9: 401] | Discontinued in Phase 2 | [1] | |
Company |
Laboratorio Guidotti SpA
|
|||
Structure |
Download2D MOL |
|||
Formula |
C11H18N2O5
|
|||
Canonical SMILES |
CN(CC(=O)NO)C(=O)C1CCCCC1C(=O)O
|
|||
InChI |
1S/C11H18N2O5/c1-13(6-9(14)12-18)10(15)7-4-2-3-5-8(7)11(16)17/h7-8,18H,2-6H2,1H3,(H,12,14)(H,16,17)/t7-,8+/m1/s1
|
|||
InChIKey |
QKIVRALZQSUWHH-SFYZADRCSA-N
|
|||
CAS Number |
CAS 127420-24-0
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Angiotensin-converting enzyme (ACE) | Target Info | Inhibitor | [2] |
KEGG Pathway | Renin-angiotensin system | |||
Chagas disease (American trypanosomiasis) | ||||
Hypertrophic cardiomyopathy (HCM) | ||||
Pathwhiz Pathway | Angiotensin Metabolism | |||
Reactome | Metabolism of Angiotensinogen to Angiotensins | |||
WikiPathways | ACE Inhibitor Pathway | |||
Metabolism of Angiotensinogen to Angiotensins |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002045) | |||
REF 2 | Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors. J Cardiovasc Pharmacol. 1992 Jul;20(1):139-46. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.